Astragaloside IV ameliorates radiation‐induced nerve cell damage by activating the BDNF / TrkB signaling pathway
Phytotherapy Research · 2023-09 · 37 (9) · 4102-4116
DOI: 10.1002/ptr.7872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 24.05.2023. Verfasst von Xin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Institute of Neuroscience, Chinese Academy of Sciences Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, The Major Gansu Province Research Development Program.
Abstract (Originalsprache)
Radiation can induce nerve cell damage. Synapse connectivity and functionality are thought to be the essential foundation of all cognitive functions. Therefore, treating and preventing damage to synaptic structure and function is an urgent challenge. Astragaloside IV (AS‐IV) is a glycoside extracted from Astragalus membranaceus (Fisch.). Bunge is a widely used traditional Chinese medicine in China with various pharmacological properties, including protective effects on the central nervous system (CNS). In this study, the effect of AS‐IV on synapse damage and BDNF/TrkB signaling pathway in radiated C57BL/6 mice with X‐rays was investigated. PC12 cells and primary cortical neurons were exposed to UVA in vitro. Open field test and rotarod test were used to observe the effects of AS‐IV on the motor and explore the abilities of radiated mice. The pathological changes in the brain were observed by hematoxylin and eosin and Nissl staining. Immunofluorescence analysis was used to detect the synapse damage. The expressions of the BDNF/TrkB pathway and neuroprotection‐related molecules were detected by Western blotting and Quantitative‐RTPCR, respectively. The results showed that AS‐IV could improve the motor and explore abilities of radiated mice, reduce pathological damage to the cortex, enhance neuroprotection functions, and activate BDNF/TrkB pathway. In conclusion, AS‐IV could relieve radiation‐induced synapse damage, at least partly through the BDNF/TrkB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou, China.
- School of Life Sciences, Northwest Normal University, Lanzhou, China.
- School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
ORCID-Profile: Xin Liu, Shengxiang Zhang
Förderung
- National Natural Science Foundation of China
- Institute of Neuroscience, Chinese Academy of Sciences Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences
- The Major Gansu Province Research Development Program
- Major State Basic Research Development Program
Zitieren
APA
Liu, X., Ding, Y., Jiang, C., Ma, X., Xin, Y., Li, Y., Zhang, S., & Shao, B. (2023). Astragaloside IV ameliorates radiation‐induced nerve cell damage by activating the BDNF / TrkB signaling pathway. Phytotherapy Research, 37(9), 4102-4116. https://doi.org/10.1002/ptr.7872
Vancouver
Liu X, Ding Y, Jiang C, Ma X, Xin Y, Li Y, et al. Astragaloside IV ameliorates radiation‐induced nerve cell damage by activating the BDNF / TrkB signaling pathway. Phytotherapy Research. 2023;37(9):4102-4116. doi:10.1002/ptr.7872
BibTeX
@article{Liu2023,
author = {Liu, Xin and Ding, Yanping and Jiang, Chenxin and Ma, Xin and Xin, Yuanyuan and Li, Yingdong and Zhang, Shengxiang and Shao, Baoping},
title = {Astragaloside IV ameliorates radiation‐induced nerve cell damage by activating the BDNF / TrkB signaling pathway},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {9},
pages = {4102--4116},
doi = {10.1002/ptr.7872}
}
EUVIMED